Genezen

📍 Indianapolis, United States🗓 Founded 2014👥 174 employees💰 Last funded Apr 2021
Biotechnology Research🌐 genezen.com
Website LinkedIn
Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the companys expansive knowledge and experience in the industry and working with the nations leading institutions. For more information, or to learn more about services offered in Genezens new cGMP facility, please visit our website: www.genezen.com
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Genezen?
Genezen has 1 investors on record on gritt.io and 1 late-stage investors.
When did Genezen last raise funding?
The most recent investment in Genezen recorded on gritt.io was in April 2021.
When was Genezen founded?
Genezen was founded in 2014.
What industry is Genezen in?
Genezen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Genezen based?
Genezen is headquartered in Indianapolis, United States.